GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Iperion Ltd (NZSE:IPR) » Definitions » Short-Term Debt

Iperion (NZSE:IPR) Short-Term Debt : NZ$0.00 Mil (As of Sep. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Iperion Short-Term Debt?

Iperion's Short-Term Debt for the quarter that ended in Sep. 2023 was NZ$0.00 Mil.


Iperion Short-Term Debt Historical Data

The historical data trend for Iperion's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iperion Short-Term Debt Chart

Iperion Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Iperion Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Iperion Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Iperion Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Iperion's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Iperion Business Description

Traded in Other Exchanges
N/A
Address
c/o Duncan Cotterill, 50 Customhouse Quay, Level 5 Tower Building, Wellington, NTL, NZL, 6011
Iperion Ltd is engaged in the process of commercializing a novel antimicrobial coating product, being marketed under the name Pathoglaze.

Iperion Headlines

No Headlines